Long-term outcomes of phakic patients with diabetic macular oedema treated with intravitreal fluocinolone acetonide (FAc) implants

PURPOSE: Diabetic macular oedema (DMO) is a leading cause of blindness in working-age adults. Slow-release, nonbioerodible fluocinolone acetonide (FAc) implants have shown efficacy in the treatment of DMO; however, the National Institute for Health and Care Excellence recommends that FAc should be u...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eye (Lond)
Main Authors: Yang, Y, Bailey, C, Holz, F G, Eter, N, Weber, M, Baker, C, Kiss, S, Menchini, U, Ruiz Moreno, J M, Dugel, P, Lotery, A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565956/
https://ncbi.nlm.nih.gov/pubmed/26113503
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.98
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados